Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/08/2000EP1049482A1 Method of producing elastin, elastin-based biomaterials and tropoelastin materials
11/08/2000EP1049479A1 Analgesic from snake venom
11/08/2000EP1049465A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
11/08/2000EP0910662B1 Methods and reagents for typing hla class i genes
11/08/2000EP0734396B1 ANALOGUES OF hGH-RH (1-29)NH2 HAVING ANTAGONISTIC ACTIVITY
11/08/2000EP0687180B1 Methods for detection and treatment of individuals having abnormal cells expressing hla-a2/tyrosinase peptide antigens
11/08/2000EP0636029B1 Antibodies specific for carcinoma-associated antigens
11/08/2000EP0635132B1 Broadly reactive opsonic antibodies that react with common staphylococcal antigens
11/08/2000EP0633944B1 Method of multiplex ligase chain reaction
11/08/2000CN1272885A Method of increasing fruit size in plant
11/08/2000CN1272884A Adipocyte-specific protein homologs
11/08/2000CN1272883A Adipocyte-specific protein homologs
11/08/2000CN1272882A Chimeric polypeptide comprising fragment B of shiga toxin and peptides of therapeutic interest
11/08/2000CN1272876A Gram negative coccoid bacterium
11/08/2000CN1272760A Hypersensitive response elicitor from i (erwinia amylovora), its use and encoding gene
11/08/2000CN1272550A Preparation method of natural folding and secreted protein
11/08/2000CN1272548A Transgenic avian bioreactor and method for producing recombinant protein or polypeptide by using one
11/08/2000CN1272547A Human prenylation Rab conjugated protein and its coded sequence
11/08/2000CN1272545A Human neurogenic glutamine transport protein and its coded sequence
11/08/2000CN1272544A Human bladder protein and its coded sequence
11/08/2000CN1272543A Human gene expression regulatory factor related protein and its coded sequence
11/08/2000CN1272542A Human protein phosphoglycan protein and its coded sequence
11/08/2000CN1272541A Human trans-Golgi network protein isomer and its coded sequence
11/08/2000CN1272540A Human immune factor related protein and its coded sequence
11/08/2000CN1272539A Human cytodiaeresis inhibition factor protein and its coded sequence
11/08/2000CN1058296C Antibody heteroconjugates for use in regulation lymphocyte activity
11/07/2000US6143963 Waxy wheat starch type having waxy proteins in granule
11/07/2000US6143880 Pig myogenin gene and method to identify polymorphisms related to muscle growth
11/07/2000US6143878 Sox-9 gene and protein and use in the regeneration of bone or cartilage
11/07/2000US6143876 Immunogenic antigenic epitope which is a member of a binding couple; for production of antibodies with increased affinity; diagnosis; treatment; vaccines; viricides against human immunodeficiency virus
11/07/2000US6143874 Antibodies to the neurotrophic factor NNT-1
11/07/2000US6143872 Polypeptide encoded by dna having defined nucleotide sequence; early diagnosis of lyme disease using polymerase chain reaction primers; vaccines
11/07/2000US6143871 IL-13 and IL-4 binding polypeptides
11/07/2000US6143870 Thrombin receptor homolog
11/07/2000US6143869 CD30 ligand oligomers and polypeptides
11/07/2000US6143867 Amino acid sequence; for diagnosis, prevention, and treatment of late-phase allergic/inflammatory reactions, eosinophilias, parasitic infections, conditions associated with placental derived-basic protein accumulation in pregnancy
11/07/2000US6143866 Analog of a defined amino acid sequence; for treatment of septic shock and cachexia
11/07/2000US6143865 Amino acid sequences which are reactive with viral antibodies; for accurate and sensitive immunoassay diagnosis
11/07/2000US6143864 Peptides
11/07/2000US6143727 Aministering loricrin or k6 keratin expression vector at or directly around the site of skin cancer cell nucleic acid to result inhibition of the cell's proliferation to treat skin cancer
11/07/2000US6143720 Lipocalin homologs
11/07/2000US6143719 Bradykinin analogs as selective thrombin inhibitors
11/07/2000US6143715 For treating and prevention of hepatitis c viurs infections
11/07/2000US6143714 Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons
11/07/2000US6143565 Transforming insect cell line by isolating calyx fluid containing braconid polydnavirus from female parasitic wasp, adding fluid to culture of insect cells, incubating for viral dna to be incorporated into genome of the cells
11/07/2000US6143550 Bacillus thuringiensis strains and their insecticidal proteins
11/07/2000US6143527 Chain reaction cloning using a bridging oligonucleotide and DNA ligase
11/07/2000US6143526 Dna which encodes a spinosyn biosynthetic enzyme of defined amino acid sequence; for novel polyketides
11/07/2000US6143524 Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
11/07/2000US6143523 Nucleotide sequences coding somatotropin; for treatment of defect associated with reduction in somatotropin
11/07/2000US6143522 Activating programmed cell death in eukaryotic cells; amplifying theexpression of peptides or oligonucleotides associated with programmed cell death in eukaryotic cells
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143520 Expression vectors and methods of use
11/07/2000US6143519 Human endothelin-bombesin receptor
11/07/2000US6143518 Expression vectors comprising nucleotide sequences which for code heterologous polypeptides which can be expressed in bacteria
11/07/2000US6143511 Contacting nonhydrolyzed body fluid sample with first and second antibodies to form complex, detecting presence or amount of complex, wherein antibodies bind to telopeptide having sequence identical to that produced in vivo
11/07/2000US6143509 Prostate specific antigen peptides and uses thereof
11/07/2000US6143498 Antimicrobial peptide
11/07/2000US6143493 HCMV-specific peptides, agents therefor and the use thereof
11/07/2000US6143491 Detecting insulin defect in humans; screening for adjustment in amino acid sequence
11/07/2000US6143305 Antigenically modified polypeptides composition
11/07/2000US6143299 Compositions and methods using complexes of heat shock protein gp96 and antigenic molecules for the treatment and prevention of infectious diseases
11/07/2000US6143298 Soluble truncated forms of ICAM-1
11/07/2000US6143297 Immunizing a mammals; forming antibodies
11/07/2000US6143296 Antibody 67D2
11/07/2000US6143295 Low molecular weight protein
11/07/2000US6143291 Methods for modulating T cell survival by modulating bcl-XL protein level
11/07/2000US6143290 Tumor regression by adenovirus expression of wild-type p53
11/07/2000US6143289 Compositions of myeloid-cell-suppressive chemokines
11/07/2000US6143280 Color containing silica resistant to dye migration and method of making the same
11/07/2000US6143275 Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
11/07/2000US6143273 Useful as immunosuppressants, as well as antibodies capable of preventing the specific binding of the lag-3 protein to major histocompatibility complex class ii molecules as immunostimulants
11/07/2000US6143247 Affinity binding-based system for detecting particulates in a fluid
11/07/2000US6143179 Method for the affinity-chromatographic purification of factor VIII
11/07/2000US6142092 Depth control device
11/07/2000CA2180657C Synthetic antimicrobial peptides
11/07/2000CA2166981C Oncoprotein protein kinase
11/07/2000CA2075711C Vaccine and method therefor
11/07/2000CA2034100C A method of preparing a fibrinogen concentrate from blood plasma, a device for carrying out said method, and a method of preparing fibrinogen from said concentrate
11/07/2000CA2024767C Interferon-gamma receptor fragment and its production
11/07/2000CA1341133C Chlamydia major outer membrane protein
11/02/2000WO2000065340A1 Protein-protein interactions
11/02/2000WO2000065090A2 The insulin receptor-related receptor gene sequence for diagnosis of human obesity and diabetic disorders
11/02/2000WO2000065080A1 Antibiotic-based gene regulation system
11/02/2000WO2000065078A1 A herpes simplex virus type 1 (hsv-1)-derived vector for selectively inhibiting malignant cells and methods for its use to treat cancers and to express desired traits in malignant and non-malignant mammalian cells
11/02/2000WO2000065077A1 Triple hybrid amplicon vector systems to generate retroviral packaging lines
11/02/2000WO2000065076A2 Synthetic gene for expressing active retroviral protein in eukaryotes
11/02/2000WO2000065075A1 Use of coxsackie viruses for improving cell transfection
11/02/2000WO2000065074A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
11/02/2000WO2000065065A1 METHOD FOR OBTAINING RECOMBINANT HBsAg
11/02/2000WO2000065064A1 Peptides and assays for the diagnosis of lyme disease and compositions useful for the prevention thereof
11/02/2000WO2000065063A2 Nucleic acid vaccines against rickettsial diseases and methods of use
11/02/2000WO2000065062A2 Genome sequence and polypeptides of pyrococcus abissy, fragment and uses thereof
11/02/2000WO2000065061A2 Nucleic acid sequences from candida yeasts which code cytochrome b5 polypeptides
11/02/2000WO2000065060A2 Dna sequence and recombinant production of a graminae allergen
11/02/2000WO2000065059A1 Splicing factor
11/02/2000WO2000065058A1 Method for down-regulating il5 activity
11/02/2000WO2000065056A2 NUCLEIC ACIDS ENCODING A MutT DOMAIN-CONTAINING POLYPEPTIDE
11/02/2000WO2000065055A2 Human transporter proteins
11/02/2000WO2000065054A2 Human membrane-associated proteins